Comment on: Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL
| Image |  |
|---|---|
| Description | scientific article published on 14 April 2020 |
| Author/s |
author: Marco Berruti Antonio Di Biagio |
| Publication date | April 14, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |